Brief: IN8bio Announces First Patient Cohort Dosed In Phase 1 Clinical Trial Of INB-100
Brief: IN8bio Appoints Emily Fairbairn And Luba Greenwood To Board
Brief: In8bio Inc Shares Open Flat In Debut On Nasdaq
Brief: In8bio Announces Pricing Of Initial Public Offering
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:01 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:01 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM